Hans-Ulrich Demuth,Fred Rosche,Joem Schmidt,Robert P. Pauly,Christopher H.S. McIntosh,Ray A. Pederson
申请号：
US15042892
公开号：
US20170007582A1
申请日:
2016.02.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention comprises the use of activity-reducing effectors of dipeptidyl peptidase (DP IV) and DP IV-analogous enzyme activity in the blood of a mammal to lower elevated post-prandial and basal blood glucose levels in mammalian organisms.The invention further comprises the use of activity-reducing effectors of dipeptidyl peptidase (DP IV) and DP IV-analogous enzyme activity in the blood of a mammal to increase the half-life of incretins in vivo.
